1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Rafael Holdings Acquires Rafael Pharmaceuticals

M&A Deal Summary

Rafael Holdings Acquires Rafael Pharmaceuticals

On January 23, 2019, Rafael Holdings acquired life science company Rafael Pharmaceuticals

Acquisition Highlights
  • This is Rafael Holdings’ 1st transaction in the Life Science sector.
  • This is Rafael Holdings’ 1st transaction in the United States.
  • This is Rafael Holdings’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2019-01-23
Target Rafael Pharmaceuticals
Sector Life Science
Buyer(s) Rafael Holdings
Deal Type Add-on Acquisition

Target

Rafael Pharmaceuticals

Newark, New Jersey, United States
Rafael Pharmaceuticals, Inc. is a clinical stage, metabolic oncology-therapeutics company developing innovative, highly selective and well tolerated anti-cancer agents. Rafael Pharmaceuticals was founded in 2000 and is based in Newark, New Jersey.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Rafael Holdings

Newark, New Jersey, United States
Category Company
Sector Business Services
DESCRIPTION

Rafael Holdings, Inc. is a provider of commercial real estate assets and interests in two clinical-stage pharmaceutical companies. Rafael Holdings is based in Newark, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal